Volker Herrmann

Volker Herrmann, MD, currently serves as the CEO of Sonata Therapeutics and CEO Partner at Flagship Pioneering, a role held since August 2020. Prior experience includes serving as the Chief Operating Officer at SQZ Biotechnologies and Selenity Therapeutics, as well as the Chief Commercial Officer at Viamet Pharmaceuticals. Herrmann held various leadership positions at Pfizer from 1999 to 2015, culminating as Head of Global Commercial Development, Global Marketing & Global Strategy for Pfizer Vaccines. Academically, Herrmann earned a Doctor of Medicine degree in Cardiology and a PhD in Pharmacology from the University of Freiburg, alongside an MBA from the University of San Diego and a Doctor of Medicine degree from the University of Michigan.